Julia Boshuizen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.
Journal: Journal for immunotherapy of cancer
Published: August 09, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.
Journal: Cancer cell
Published: July 07, 2023
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Journal: Nature communications
Published: February 07, 2023
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 29, 2020
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.
Journal: Nature communications
Published: July 08, 2020
Rational Cancer Treatment Combinations: An Urgent Clinical Need.
Journal: Molecular cell
Published: February 14, 2020
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.
Journal: Cancer research
Published: February 05, 2020
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Journal: Cell
Published: January 25, 2020
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Journal: Nature communications
Published: November 19, 2019
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Journal: Cell
Published: May 24, 2018
Last Updated: 09/26/2026